Medtronic PLC
$ 81.67
-0.32%
05 Jun - close price
- Market Cap 105,188,696,000 USD
- Current Price $ 81.67
- High / Low $ 82.68 / 81.11
- Stock P/E 21.97
- Book Value 38.17
- EPS 3.73
- Next Earning Report -
- Dividend Per Share $2.84
- Dividend Yield 3.64 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.10 %
- 52 Week High 104.70
- 52 Week Low 73.31
About
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Analyst Target Price
$103.15
Quarterly Earnings
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | Jul 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-06-03 | 2026-02-17 | 2025-11-18 | 2025-08-19 | 2025-05-21 | 2025-02-18 | 2024-11-19 | 2024-08-20 | 2024-05-23 | 2024-02-20 | 2023-11-21 | 2023-08-22 |
| Reported EPS | 1.55 | 1.36 | 1.36 | 1.26 | 1.62 | 1.39 | 1.26 | 1.23 | 1.46 | 1.3 | 1.25 | 1.2 |
| Estimated EPS | 1.56 | 1.34 | 1.31 | 1.23 | 1.58 | 1.36 | 1.25 | 1.2 | 1.45 | 1.26 | 1.18 | 1.11 |
| Surprise | -0.01 | 0.02 | 0.05 | 0.03 | 0.04 | 0.03 | 0.01 | 0.03 | 0.01 | 0.04 | 0.07 | 0.09 |
| Surprise Percentage | -0.641% | 1.4925% | 3.8168% | 2.439% | 2.5316% | 2.2059% | 0.8% | 2.5% | 0.6897% | 3.1746% | 5.9322% | 8.1081% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-04-17 | 2026-01-16 | 2025-10-17 | 2025-07-11 | 2025-04-11 | 2025-01-10 | 2024-10-11 | 2024-07-12 | 2024-04-12 | 2024-01-12 |
| Amount | $0.71 | $0.71 | $0.71 | $0.71 | $0.7 | $0.7 | $0.7 | $0.7 | $0.69 | $0.69 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MDT
2026-06-06 01:37:54
CereVasc has successfully raised $85 million in Series C financing, with significant contributions from Johnson & Johnson’s corporate venture capital arm and Medtronic. This funding will support an ongoing pivotal trial for the company's minimally invasive eShunt technology, designed to treat normal pressure hydrocephalus, a condition characterized by fluid buildup in the brain. The eShunt aims to offer a safer and less invasive alternative to traditional surgical shunts, with primary completion of the trial estimated for December, paving the way for future premarket approval and U.S. commercialization.
2026-06-05 11:39:59
Beta Bionics, Inc. recently saw its President, Sean Saint, sell US$213k worth of shares, representing 3.9% of his total holding. While this was the largest insider sale in the past year, no insiders have purchased shares during the same period. Despite a strong insider ownership of 5.6%, the history of sales leads to a cautious outlook on the stock.
2026-06-05 10:56:31
Stryker (SYK) recently introduced two orthopaedic innovations: the TPX HD small bone power tool and the Pangea Plating System in Europe, targeting complex revision and fracture procedures. These launches align with Stryker's strategy for steady procedure growth and international expansion. While promising, investors should consider potential challenges like European regulatory timelines and supply chain pressures, especially as the company forecasts significant revenue and earnings growth by 2029.
2026-06-05 10:51:17
Insulet's Independent Chair, Elizabeth Weatherman, recently purchased US$497k worth of company stock at US$144 per share, increasing her holding by 66%. This insider purchase, along with a larger US$1.0m purchase by the CEO at a higher price, suggests strong insider confidence in the company's future value. Overall, Insulet insiders bought more shares than they sold over the past year.
2026-06-05 10:38:56
Lifestyle Asset Management Inc. reduced its stake in Western Digital Corporation by 16.2%, selling 3,155 shares and retaining 16,284 shares valued at $2.8 million. Despite this sale, institutional investors continue to hold a significant portion of Western Digital, with 92.51% of shares owned by hedge funds and a consensus "Moderate Buy" rating from analysts. The company has shown strong performance, beating earnings and revenue estimates, and recently increased its quarterly dividend.
2026-06-05 10:20:01
The average 12-month price target for Medtronic plc. (MDT) stock has been lowered from $97.38 to $96.61 by 23 analysts. This new target implies an 18% potential upside based on the June 4th closing price. The consensus analyst rating for Medtronic remains a "Buy" from 30 analysts, with 18 recommending a Buy and 12 a Hold.
